[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500203":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Antonio Liguori, MD","Catholic University of the Sacred Heart","STUDY_CHAIR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Luca Miele, MD, PhD","CONTACT","+390630151","luca.miele@policlinicogemelli.it",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Fondazione Policlinico Universitario A. Gemelli IRCCS","RECRUITING","Rome","00181","Italy","IT",{"type":28,"coordinates":29},"Point",[30,31],12.51133,41.89193,{"lat":31,"lon":30},[34],{"name":10,"role":16,"phone":35,"phoneExt":7,"email":36},"+390630159223","lig.antonio91@gmail.com",{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100500203","single-center-prospective-study-of-non-invasive-methods-for-the-diagnosis-of-postoperative-complications-in-liver-transplant-recipients-100500203",false,"NCT05793203","Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients","ElastOLT","Inclusion Criteria:\n\n* Patients eligible for liver transplantation following National and International Guidelines\n\nExclusion Criteria:\n\n* No agreement or inability to give informed consent\n\n  * Re-transplant patients\n  * Liver transplant in fulminant hepatitis","ALL","18 Years","75 Years",{"count":50,"type":51},100,"ESTIMATED","OBSERVATIONAL","A lot of different early and late complications may occur after liver transplantation. They could be related to surgical procedure, to infectious diseases or immuno-mediated diseases (acute cellular rejection, ACR). Almost all of those complications are characterized by an elevation in liver enzymes (ALT, AST and GGT) and a decline of liver function tests (serum bilirubin and INR increase) possibly leading to early allograft disfunction (EAD). In this scenario there is a lack of biomarker that could predict the development of ACR and\u002For EAD.\n\nThe aim of this study is to explore the prognostic role of non-invasive instrumental and biological marker in the early post-transplant phase.",[55,56,57],"Rejection Acute Hepatic","Transplant; Failure, Liver","Liver Dysfunction","2023-03-20",{"date":60,"type":61},"2023-03-31","ACTUAL",{"date":63,"type":61},"2020-07-06",{"date":65,"type":51},"2027-12-31",{"name":5,"class":6},1]